financial statements for the 3rd quarter of 2017 ending 30 September 2017, the Company would like to report factors that affect the financial performance for the 3rd quarter of 2017 as follows; Statements of

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

financial statements (Thousand Bath) 30 Jun 19 % 30 Jun 18 % YOY %YOY Sales 370,857 70.66% 308,181 76.55% 62,676 20.34% Service income 48,880 9.31% 45,767 11.37% 3,113 6.80% Other income 105,131 20.03% 48,651

MDA Q2_2018 (Eng.) August 7, 2018 Subject : Interim Management Discussion and Analysis of Q2/2018 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements

Fortune Parts Industry Public Company Limited (“FPI” or “The Company”) would like to submit the annual financial statements for the three-month period ended 30 June 2020 which has been audited by certified

1,898 (729) -38% Other non-current liabilities 9 9 0 0% Total shareholders’ equity 6,098 9,016 (2,918) -32% • Total assets decline of 31% mainly are results of decrease in other non-current of financial

Management Discussion and Analysis of the Company's operation for the three-month period ended 30 September, 2019 with details as follows: Unit: Million Baht (Unit: Million Baht) Consolidated financial

the same period in 2018. The decrease in revenue resulted mainly from the decline of revenues from the manufacturing and selling of Special Cutting Tools segment, which include sales from the Company

same period in 2019. The decrease in revenue resulted mainly from the decline of revenues from the manufacturing and selling of Special Cutting Tools segment, which include sales from the Company, the

Q3/2019, the Company and its subsidiaries recorded total sales of Baht 1,205 million, an increase of 0.1% YoY, occurred from a decline in domestic branded sales at 11% YoY while export branded sales